DHR
Danaher Corporation
INDUSTRIAL INSTRUMENTS FOR MEASUREMENT, DISPLAY, AND CONTROL
Best Industrial Instruments Stocks 2026 →
Danaher (DHR) Stock: Buy, Sell, or Hold?
$232.16
-3.15 (-1.34%)
âŧ
5d:
+2.57%
30d:
+3.32%
90d:
+14.68%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Oct 21, 2026
0d
Protect DHR Gains
Updated Nov 12, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (41%)
Quality Score
50/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$222.28 â $234.35
Position: SLIGHTLY HIGH
Forward P/E & Valuation
24.9x
FAIR
vs 22.7x historical avg
Wall Street Target
$259.90
+12.0% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$222.96 / $238.46
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: DHR is fairly priced but lacks strong directional signals. At 3.1% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Nov 9, 2026 at $232.00 · last confirmed Nov 9, 2026
Strength: 5.7/10
Get Alerted When DHR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$286.31
Based on 6.3% avg growth
INTRINSIC VALUE TODAY
$177.78
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 22.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DHR is currently trading at $232.16, which is considered slightly high relative to its 30-day fair value range of $222.28 to $234.35. The stock's valuation (Forward PE: 24.9) is in line with its historical norms (22.7). At these levels, the market is pricing in 3.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DHR is in a strong uptrend. The price is approaching resistance at $238.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DHR scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $259.90 (+12.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DHR is in a strong uptrend. The price is approaching resistance at $238.46. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: DHR scores 30/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $259.90 (+12.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$222.28 -
$234.35
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
41.4%
Trading Range & Key Levels
30-Day Trading Range
$222.28 -
$234.35
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$222.96
Resistance Level
$238.46
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Protect Your Profits
Holding DHR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BEARISH: Weak technical setup (30/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($259.90)
- NEUTRAL: Market pricing in 3.1% annual earnings growth - fairly valued
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
24.91
Wall Street Target
$259.90
(+12.0%)
Revenue Growth (YoY)
8.3%
Earnings Growth (YoY)
37.8%
Profit Margin
16.9%
Valuation Premium vs History
+3.1% premium
PE vs Historical
24.9 vs 22.7
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.1%
(market-implied from PE analysis)
1-Year Target
$239.36
(+3%)
2-Year Target
$246.78
(+6%)
3-Year Target
$254.43
(+10%)
3-Yr Target (if PE normalizes)
(PE: 25â23)
PE COMPRESSION
$231.85
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 24.9, Growth: 8.5%)
$296.38
(+28%)
Base:
(SPY PE: 19.9, Growth: 8.5%)
$236.29
(+2%)
Bear:
(PE: 16.9, Growth: 8.5%)
$200.85
(-14%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (39x PE), but valuation improves significantly next year (25x PE) as earnings recover.
Trailing PE: 38.96 | Current EPS (TTM): $6.04
Bull Case
$399.40
(+72%)
Analyst growth 54.3%, PE expands to 42.9
Base Case
$363.09
(+56%)
Market implied 54.3%, PE stable at 39.0
Bear Case
$160.01
(-31%)
Severe decline -20.0%, PE contracts to 33.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share DHR Analysis
Share this live DHR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (DHR)
Bearish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 21, 2026
Daily AI digest
AI Retail Discussion Summary:
NVIDIA collaborates with healthcare and life sciences leaders, including Danaher, to advance protein design, accelerate drug discovery, and bring greater precision to cancer care.
Key Retail Themes:
Protein design
Drug discovery
Cancer care
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:02 PM ET
Data refreshes hourly during market hours. Next update: 8:02 PM
Data refreshes hourly during market hours. Next update: 8:02 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DHR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
DHR is a key holding in these high-performance investment strategies.
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
GH
Guardant Health Inc |
STRONG BUY
26 analysts |
$201 | 56 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
23 analysts |
$416 | 67 BUY |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
27 analysts |
$752 | 48 HOLD |
|
IQV
IQVIA Holdings Inc |
STRONG BUY
20 analysts |
$312 | 55 HOLD |
Advanced DHR Option Strategies
Professional options setups generated by AI based on today's DHR price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive DHR Research Pages
